Strong evidence points to APP potentially functioning as a copper efflux protein in neurons, and its overexpression could be responsible for the observed copper deficiency in the brains of most AD transgenic mouse models (Lin et al., 2010). The gene discussed is APP; the disease is Alzheimer disease.